Major histocompatibility complex molecules on parenchymal cells of the target organ protect against autoimmune disease

Chemical Immunology and Allergy

Volumn 92, Issue , 2007, Pages 94-104

  Shao, Hui ^a   Kaplan, Henry J ^a   Sun, Deming ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 15; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NITRIC OXIDE; RETINA ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; HLA ANTIGEN CLASS 2;

ADOPTIVE TRANSFER; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE DISEASE; CELL INTERACTION; CYTOKINE PRODUCTION; CYTOTOXICITY; DISEASE COURSE; DISEASE EXACERBATION; HUMAN; HYPOTHESIS; IMMUNE RESPONSE; INFLAMMATION; INHIBITION KINETICS; LYMPHOCYTE TRANSFER; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NONHUMAN; PARENCHYMA; PATHOGENESIS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TARGET ORGAN; TISSUE INJURY; UVEITIS; AMINO ACID SEQUENCE; ANIMAL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOLECULAR GENETICS; PHYSIOLOGY; REVIEW; T LYMPHOCYTE;

ADOPTIVE TRANSFER; AMINO ACID SEQUENCE; ANIMALS; AUTOIMMUNE DISEASES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; PIGMENT EPITHELIUM OF EYE; T-LYMPHOCYTES; UVEITIS;

EID: 33947500770     PISSN: 16602242     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000099260     Document Type: Article

References (64)

1. Burns J, Rosenzweig A, Zweiman B, et al: Isolation of myelin basic protein-reactive T-cell lines from normal human blood. Cell Immunol 1983;81:435-440.
2. Schlüsener HJ, Wekerle H: Autoaggressive T lymphocyte lines recognizing the encephalitogenic region of myelin basic protein: In vitro selection from unprimed rat T lymphocyte populations. J Immunol 1985;135:3128-3133.
3. Massa PT, ter Meulen V, Fontana A: Hyperinducibility of Ia antigen on astrocytes correlates with strain-specific susceptibility to experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 1987;84:4219-4223.
4. Chung IY, Norris JG, Benveniste EN: Differential tumor necrosis expression by astrocytes from experimental allergic encephalomyelitis-susceptible and -resistant rat strains. J Exp Med 1991;173:801-811.
5. Shao H, Sun SL, Kaplan HJ, et al: Characterization of rat CD8+ uveitogenic T cells specific for interphotoreceptor retinal-binding protein 1177-1191. J Immunol 2004;173:2849-2854.
6. Donoso LA, Merryman CF, Sery T, et al: Human interstitial retinoid binding protein: A potent uveitopathogenic agent for the induction of experimental autoimmune uveitis. J Immunol 1989;143: 79-83.
7. Chan CC, Nussenblatt RB, Wiggert B, et al: Immunohistochemical analysis of experimental autoimmune uveoretinitis (EAU) induced by interphotoreceptor retinoid-binding protein (IRBP) in the rat. Immunol Invest 1987;16:63-74.
8. Caspi RR: Experimental autoimmune uveoretinitis - rat and mouse; in Cohen IR (ed): Animal Models for Autoimmune Diseases: A Guidebook. New York, Academic Press, 1994, p 57.
9. Silver PB, Rizzo LV, Chan CC, et al: Identification of a major pathogenic epitope in the human IRBP molecule recognized by mice of the H-2r haplotype. Invest Ophthalmol Vis Sci 1995;36: 946-954.
10. Shao H, Peng Y, Liao T, et al: A shared epitope of the interphotoreceptor retinoid-binding protein recognized by the CD4+ and CD8+ autoreactive T cells. J Immunol 2005;175:1851-1857.
11. Shao H, Liao T, Ke Y, et al: Severe chronic experimental autoimmune uveitis (EAU) of the C57BL/6 mouse induced by adoptive transfer of IRBP1-20-specific T cells. Exp Eye Res 2006;82:323-331.
12. Shao H, Song L, Sun SL, et al: Conversion of monophasic to recurrent autoimmune disease by autoreactive T cell subsets. J Immunol 2003;171:5624-5630.
13. Sun D, Hu X, Le J, et al: Characterization of brain-isolated rat encephalitogenic T cell lines. Eur J Immunol 1994;24:1359-1364.
14. Sun D, Le J, Coleclough C: Diverse T cell receptor β chain usage by rat encephalitogenic T cells reactive to residues 68-88 of myelin basic protein. Eur J Immunol 1993;23:494-498.
15. b8 T cell receptors. Eur J Immunol 1992;22:591-594.
16. Shao H, Fu YX, Song L, et al: LTbR-Ig treatment blocks actively induced, but not adoptively transferred, uveitis in Lewis rats. Eur J Immunol 2003;33:1743.
17. Shao H, Fu Y, Liao T, et al: Anti-CD137 mAb treatment inhibits experimental autoimmune uveitis by limiting expansion and increasing apoptotic death of uveitogenic T cells. Invest Ophthalmol Vis Sci 2005;46:596-603.
18. Sun D, Hu X, Shah R, et al: Production of tumor necrosis factor-α as a result of glia-T-cell interaction correlates with the pathogenic activity of myelin basic protein-reactive T cells in experimental autoimmune encephalomyelitis. J Neurosci Res 1996;45:400-409.
19. Sun D, Coleclough C, Whitaker JN: Nonactivated astrocytes downregulate T cell receptor expression and reduce antigen-specific proliferation and cytokine production of myelin basic protein (MBP)-reactive T cells. J Neuroimmunol 1997;78:69-78.
20. Sun D, Hu XZ, Liu XH, et al: Expression of chemokine genes in rat glial cells: The effect of myelin basic protein-reactive encephalitogenic T cells. J Neurosci Res 1997;48:192-200.
21. Olsson T, Sun J, Hillert J, et al: Increased numbers of T cells recognizing multiple myelin basic protein epitopes in multiple sclerosis. Eur J Immunol 1992;22:1083-1087.
22. Sun D, Wilson DB, Cao L, et al: The role of regulatory T cells in Lewis rats resistant to EAE. J Neuroimmunol 1998;81:177-183.
23. Werdelin O, McCluskey RT: The nature and the specificity of mononuclear cells in experimental autoimmune inflammations and the mechanisms leading to their accumulation. J Exp Med 1971;133:1242-1263.
24. Zinn KM, Benjamin-Henkind JV: Anatomy of the human retinal pigment epithelium; in Zinn KM, Marmor MF (eds): The retinal pigment epithelium. Cambridge, Harvard University Press, 2002, pp 3-31.
25. + T-cells. Graefes Arch Clin Exp Ophthalmol 1999;237:934-939.
26. Faure V, Courtois Y, Goureau O: Inhibition of inducible nitric oxide synthase expression by α and β in bovine retinal pigmented epithelial cells. J Biol Chem 1997;272:32169-32175.
27. Holtkamp GM, Kijlstra A, Peek R, et al: Retinal pigment epithelium-immune system interactions: Cytokine production and cytokine-induced changes. Prog Retin Eye Res 2001;20:29-48.
28. Liversidge J, Forrester JV: Antigen processing and presentation in the eye: A review. Curr Eye Res 1992;11:49-58.
29. Griffith TS, Brunner T, Fletcher SM, et al: Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995;270:1189-1192.
30. Griffith TS, Ferguson TA: The role of FasL-induced apoptosis in immune privilege. Immunol Today 1997;18:240-244.
31. Jorgensen A, Wiencke AK, la Cour M, et al: Human retinal pigment epithelial cell-induced apoptosis in activated T cells. Invest Ophthalmol Vis Sci 1998;39:1590-1599.
32. Crane IJ, Kuppner MC, Mckillop-Smith S, et al: Cytokine regulation of RANTES production by human retinal pigment epithelial cells. Cell Immunol 1998;184:37-44.
33. Crane IJ, Wallace CA, Mckillop-Smith S, et al: Control of chemokine production at the blood-retina barrier. Immunology 2000;101:426-433.
34. Devine L, Lightman S, Greenwood J: Lymphocyte migration across the anterior and posterior blood-retinal barrier in vitro. Cell Immunol 1996;168:267-275.
35. Jaffe GJ, Van Le L, Valea F, et al: Expression of interleukin-1 alpha, interleukin-1 beta, and an interleukin-1 receptor antagonist in human retinal pigment epithelial cells. Exp Eye Res 1992;55:325-335.
36. Kumaki N, Anderson DM, Cosman D, et al: Expression of interleukin-15 and its receptor by human fetal retinal pigment epithelial cells. Curr Eye Res 1996;15:876-882.
37. Liversidge J, Grabowski P, Ralston S, et al: Rat retinal pigment epithelial cells express an inducible form of nitric oxide synthase and produce nitric oxide in response to inflammatory cytokines and activated T cells. Immunology 1994;83:404-409.
38. Hamel CP, Detrick B, Hooks JJ: Evaluation of Ia expression in rat ocular tissues following inoculation with interferon-gamma. Exp Eye Res 1990;50:173-182.
39. Osusky R, Dorio RJ, Arora YK, et al: MHC class II positive retinal pigment epithelial (RPE) cells can function as antigen-presenting cells for microbial superantigen. Ocul Immunol Inflamm 1997;5:43-50.
40. Percopo CM, Hooks JJ, Shinohara T, et al: Cytokine-mediated activation of a neuronal retinal resident cell provokes antigen presentation. J Immunol 1990;145:4101-4107.
41. Zinkernagel R, Doherty PC: H-2-compatibility requirement for T cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus: Different cytotoxic T cell specificities are associated with structures from H-2K or H-2D. J Exp Med 1975;141:1427-1436.
42. Wong GMW, Bartlett PF, Clark-Lewis I, et al: Inducible expression of H-2 and Ia antigens on brain cells. Nature 1984;310:688-691.
43. Traugott U, Scheinberg LC, Raine CS: On the presence of Ia-positive endothelial cells and astrocytes in multiple sclerosis lesions and its relevance to antigen presentation. J Neuroimmunol 1985;8:1.
44. Sun D, Enzmann V, Lei S, et al: Retinal pigment epithelial cells activate uveitogenic T cells when they express high levels of MHC class II molecules, but inhibit T cell activation when they express restricted levels. J Neuroimmunol 2003;144:1-8.
45. Benson MT, Shepherd L, Cottam D, et al: The expression of class I major histocompatibility antigens by human retinal pigment epithelium in vitro. Graefes Arch Clin Exp Ophthalmol 1992;230:184-187.
46. Detrick B, Newsome DA, Percopo CM, et al: Class II antigen expression and gamma interferon modulation of monocytes and retinal pigment epithelial cells from patients with retinitis pigmentosa. Clin Immunol Immunopathol 1985;36:201-211.
47. de KY, Naud MC, Bellot J, et al: Differential tumor necrosis factor expression by resident retinal cells from experimental uveitis-susceptible and -resistant rat strains. J Neuroimmunol 1994;55: 1-9.
48. Schwartz RH: CostimulationTof T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992;71:1065-1068.
49. Jenkins MK, Schwartz R: Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med 1987;165:302-310.
50. + T cells by a self-derived peptide. Nature 1995;378:295-298.
51. Evavold BD, Allen PM: Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 1991;252:1308-1310.
52. Sloan-Lancaster J, Shaw AS, Rothbard JB, et al: Partial T cell signaling: Altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy. Cell 1994;79:913-922.
53. + T cells in response to antagonist ligands. J Exp Med 1996;184:149-157.
54. Orihuela M, Margulies DH, Yokoyama WM: The natural killer cell receptor Ly-49A recognizes a peptide-induced conformational determinant on its major histocompatibility complex class I ligand. Proc Natl Acad Sci USA 1996;93:11792-11797.
55. Shao H, Van Kaer L, Sun SL, et al: Infiltration of the inflamed eye by NKT cells in a rat model of experimental autoimmune uveitis. J Autoimmun 2003;21:37-45.
56. Sun D, Coleclough C, Hu X: Heterogeneity of rat encephalitogenic T cells elicited by variants of the MBP (68-88) peptide. Eur J Immunol 1995;25:1687-1692.
57. Sun D, Hu X, Shah R, et al: The pattern of cytokine gene expression induced in rat T cells specific for myelin basic protein depends on the type and quality of antigenic stimulus. Cell Immunol 1995;166:1-8.
58. Sun D, Le J, Yang S, et al: Major role of antigen-presenting cells in the response of rat encephalitogenic T cells to myelin basic proteins. J Immunol 1993;151:111-118.
59. + encephalitogenic T cells. Eur J Immunol 1994;24:2609-2617.
60. Pender M, McCombe PA, Yoong G, et al: Apoptosis αβ T lymphocytes in the nervous system in experimental autoimmune encephalomyelitis: Its possible implications for recovery and acquired tolerance. J Autoimmun 1992;5:401-410.
61. Wekerle H, Linington C, Lassmann H, et al: Cellular immune reactivity within the CNS. Trends Neurosci 1986;9:271-277.
62. Sun D, Wekerle H: Ia-restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presenting astrocytes. Nature 1986;320:70-72.
63. Kawakami N, Odoardi F, Ziemssen T, et al: Autoimmune CD4+ T cell memory: lifelong persistence of encephalitogenic T cell clones in healthy immune repertoires. J Immunol 2005;175: 69-81.
64. Flugel A, Berkowicz T, Ritter T, et al: Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 2001;14:547-560.